1989
DOI: 10.1016/0006-291x(89)91657-4
|View full text |Cite
|
Sign up to set email alerts
|

Captopril and hydralazine suppress atrial natriuretic peptide (ANP) gene expression in the ventricles of spontaneously hypertensive rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0
1

Year Published

1990
1990
2008
2008

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 17 publications
1
10
0
1
Order By: Relevance
“…Treatment with minoxidil produced a 1.6-2.1 fold increase in ventricular ANP mRNA, and plasma IR-ANP levels were significantly elevated when compared to the untreated controls, as shown earlier by Stasch et al (1987a). Hydralazine, another vasodilator, has been shown to have no effect on plasma IR-ANP levels (Oda et al, 1988), and even to decrease ANP mRNA levels (Fukui et al, 1989), but, on the other hand, it did not significantly change cardiac weight either.…”
Section: Chemicalsmentioning
confidence: 53%
See 1 more Smart Citation
“…Treatment with minoxidil produced a 1.6-2.1 fold increase in ventricular ANP mRNA, and plasma IR-ANP levels were significantly elevated when compared to the untreated controls, as shown earlier by Stasch et al (1987a). Hydralazine, another vasodilator, has been shown to have no effect on plasma IR-ANP levels (Oda et al, 1988), and even to decrease ANP mRNA levels (Fukui et al, 1989), but, on the other hand, it did not significantly change cardiac weight either.…”
Section: Chemicalsmentioning
confidence: 53%
“…The calcium antagonists, nitrendipine and nisoldipine reduce the spontaneously developing hypertrophy and decrease the elevated plasma IR-ANP levels (Stasch et al, 1986;1987a, b). Others have demonstrated a decrease both in relative ventricular weight and in plasma IR-ANP after chronic treatment with a calcium antagonist (Kohno et al, 1988) or angiotensin I converting-enzyme inhibitors (Kohno et al, 1987;Oda et al, 1988;Fukui et al, 1989). Minoxidil treatment, in turn, aggravated cardiac hypertrophy and produced an additional increase in plasma IR-ANP (Stasch et al, 1987a).…”
Section: Chemicalsmentioning
confidence: 99%
“…Augmented expression of these peptides in both chambers of SHR may therefore reflect sensitivity of these genes to the regulatory influence of pressure loading since modest pressure loading is also evident in the right ventricle of SHR [20]. Normalisation of systemic blood pressure in SHR attenuates augmented expression of ANP and BNP in the heart [19]. In contrast, blood pressure normalisation in rats subjected to chronic nitric oxide deficiency does not attenuate the augmented expression of IMD observed in both ventricles in that model [10].…”
Section: Discussionmentioning
confidence: 97%
“…Augmented expression in SHR hearts of the natriuretic peptides, ANP and BNP, which offset increased cardiac preload and after-load by promoting natriuresis, diuresis and vasodilatation [18] is normalised by blood pressure lowering [19]. Modest pulmonary hypertension is also present in SHR at 20 weeks [20] but right ventricular hypertrophy (RVH) is not evident in non-failing SHR hearts [21].…”
Section: Introductionmentioning
confidence: 99%
“…The amounts of total RNA obtained per gram of each tissue were 0.96 ± 0.06 mg. Quantitative measurement of ANP mRNA was performed by Northern blot hy bridization analysis as previously reported (17). In short, total RNA was denatured with 1 M glyoxal and 50% dimethylsulfoxide, elec trophoresed on 1.5% agarose gels, and trans ferred to Biodyne A membranes (Pall Ultra fine Filtration Corp., Glen Cove, NY, U.S.A).…”
Section: Methodsmentioning
confidence: 99%